These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31787700)

  • 21. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac and Carotid Markers Link With Accelerated Brain Atrophy: The AGES-Reykjavik Study (Age, Gene/Environment Susceptibility-Reykjavik).
    Sabayan B; van Buchem MA; Sigurdsson S; Zhang Q; Meirelles O; Harris TB; Gudnason V; Arai AE; Launer LJ
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2246-2251. PubMed ID: 27609370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.
    Campbell DJ; McGrady M; Prior DL; Coller JM; Boffa U; Shiel L; Liew D; Wolfe R; Stewart S; Reid CM; Krum H
    J Hypertens; 2014 Nov; 32(11):2158-65; discussion 2165. PubMed ID: 25275245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.
    van Kimmenade RR; Januzzi JL; Bakker JA; Houben AJ; Rennenberg R; Kroon AA; Crijns HJ; van Dieijen-Visser MP; de Leeuw PW; Pinto YM
    J Am Coll Cardiol; 2009 Mar; 53(10):884-90. PubMed ID: 19264247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis.
    Sanchez OA; Jacobs DR; Bahrami H; Peralta CA; Daniels LB; Lima JA; Maisel A; Duprez DA
    J Hypertens; 2015 May; 33(5):966-74. PubMed ID: 25909698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma NT-proBNP mirrors the deleterious cardiovascular and renal continuum in hypertension.
    Courand PY; Harbaoui B; Bècle C; Mouly-Bertin C; Lantelme P
    Eur J Prev Cardiol; 2017 Mar; 24(5):452-459. PubMed ID: 27920215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of plasma N-terminal pro B-type natriuretic peptide, epicardial adipose tissue, and carotid intima-media thicknesses in asymptomatic obese children.
    Saritas T; Tascilar E; Abaci A; Yozgat Y; Dogan M; Dundaroz R; Hasimi A; Yesilkaya E; Lenk MK; Kilic A
    Pediatr Cardiol; 2010 Aug; 31(6):792-9. PubMed ID: 20419296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension.
    Partanen N; Husso M; Vuolteenaho O; Sipola P; Ruskoaho H; Peuhkurinen K; Magga J
    J Hum Hypertens; 2011 Dec; 25(12):746-51. PubMed ID: 21248782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between N-terminal pro B-type natriuretic peptide and day-to-day blood pressure and heart rate variability in a general population: the Ohasama study.
    Satoh M; Hosaka M; Asayama K; Kikuya M; Inoue R; Metoki H; Tsubota-Utsugi M; Hara A; Hirose T; Obara T; Totsune K; Hoshi H; Mano N; Node K; Imai Y; Ohkubo T
    J Hypertens; 2015 Aug; 33(8):1536-41. PubMed ID: 25827428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of IGF-I with subclinical cardiovascular markers including intima-media thickness, left ventricular mass index and NT-proBNP.
    Eichner M; Wallaschofski H; Schminke U; Völzke H; Dörr M; Felix SB; Nauck M; Friedrich N
    Eur J Endocrinol; 2020 Jan; 182(1):79-90. PubMed ID: 31705797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events.
    Pedersen F; Raymond I; Kistorp C; Sandgaard N; Jacobsen P; Hildebrandt P
    J Card Fail; 2005 Jun; 11(5 Suppl):S70-5. PubMed ID: 15948105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study.
    Gaggin HK; Mohammed AA; Bhardwaj A; Rehman SU; Gregory SA; Weiner RB; Baggish AL; Moore SA; Semigran MJ; Januzzi JL
    J Card Fail; 2012 Aug; 18(8):626-34. PubMed ID: 22858078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic.
    Hamagawa K; Kubo T; Nishimura K; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    Geriatr Gerontol Int; 2017 Oct; 17(10):1648-1653. PubMed ID: 27860152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic peptide fragments as possible biochemical markers of hypertension in the elderly.
    Cappellin E; Gatti R; Antonelli G; Soldà G; Ragazzi E; De Palo EF; Spinella P
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):308-13. PubMed ID: 22498997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
    Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
    Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.